Prophylactic removal of tubes and ovaries for women with BRCA1/2 mutations

被引：0
|
作者：
不详
机构：
来源：
REPRODUCTIVE HEALTH MATTERS | 2002年 / 10卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [1] Benefit of prophylactic mastectomy for women with BRCA1 or BRCA2 mutations
    Miller, LA
    Singer, ME
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (23): : 3070 - 3070
  • [2] Benefit of prophylactic mastectomy for women with BRCA1 or BRCA2 mutations -: Reply
    Schrag, D
    Kuntz, KM
    Garber, JE
    Weeks, JC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (23): : 3071 - 3072
  • [3] Prophylactic mastectomy for women with BRCA1 and BRCA2 mutations -: Facts and controversy
    Eisen, A
    Weber, BL
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03): : 207 - 208
  • [4] Prophylactic breast surgery for women with BRCA1 and BRCA2 germline mutations
    von Smitten, K
    TUMORI, 2001, 87 (04) : S13 - S15
  • [5] Finding contentment after prophylactic interventions in women with BRCA1 or BRCA2 mutations
    Lindh, M.
    Baan, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 246 - 246
  • [6] The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations
    Grann, VR
    Jacobson, JS
    Sundararajan, V
    Albert, SM
    Troxel, AB
    Neugut, AI
    CANCER JOURNAL, 1999, 5 (05): : 283 - 292
  • [7] Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
    Rebbeck, TR
    Lynch, HT
    Neuhausen, SL
    Narod, SA
    van't Veer, L
    Garber, JE
    Evans, G
    Isaacs, C
    Daly, MB
    Matloff, E
    Olopade, OI
    Weber, BL
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21): : 1616 - 1622
  • [8] Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy
    Lu, KH
    Garber, JE
    Cramer, DW
    Welch, WR
    Niloff, J
    Schrag, D
    Berkowitz, RS
    Muto, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) : 2728 - 2732
  • [9] Oophorectomy in women with BRCA1 or BRCA2 mutations
    Burki, Talha Khan
    LANCET ONCOLOGY, 2014, 15 (04): : E156 - E156
  • [10] Estimates of the likely prophylactic effect of tamoxifen in women with high risk BRCA1 and BRCA2 mutations
    Duffy S.W.
    Nixon R.M.
    British Journal of Cancer, 2002, 86 (2) : 218 - 221
12345